Literature DB >> 10549404

Angiotensin II blunts, while an angiotensin-converting enzyme inhibitor augments, reflex sympathetic inhibition in humans.

E Miyajima1, T Shigemasa, Y Yamada, O Tochikubo, M Ishii.   

Abstract

1. The role of angiotensin (Ang)II in and the effects of angiotensin-converting enzyme (ACE) inhibitors on the regulation of sympathetic neural activity were examined in humans. 2. We measured baseline values of muscle sympathetic nerve activity (MSNA) and its reflex inhibition in 28 patients with essential hypertension with elevated plasma renin activity (PRA; > 1.0 ng/mL per h = 0.28 ng/L per s) before and after either acute or chronic oral administration of an ACE inhibitor or placebo and in 20 normotensive subjects before and after infusion of either AngII (5 ng/kg per min = 4.8 pmol/kg per min) or vehicle (5% dextrose). Muscle sympathetic nerve activity was recorded from the tibial nerve and its reflex inhibition was evaluated during pressor responses to bolus injection of phenylephrine (2 micrograms/kg, i.v.). 3. Blood pressure was significantly decreased (P < 0.01) after the acute oral administration of captopril (25 mg), accompanied by a slight increase in MSNA in patients with essential hypertension compared with control patients who received placebo administration. Reflex changes in MSNA were significantly augmented after oral administration of captopril (-4.1 +/- 0.5 vs -6.2 +/- 0.6%/mmHg, respectively; P < 0.01), with a significant reduction of plasma AngII, while they were not affected by placebo administration. 4. In contrast, acute AngII infusion was accompanied by decreases in both PRA and MSNA in normotensive subjects. Reflex changes in MSNA were significantly reduced after AngII infusion (-11.0 +/- 0.8 vs -7.4 +/- 1.0%/mmHg, respectively; P < 0.01) but not after vehicle alone. 5. Chronic ACE inhibition by 12 week oral imidapril administration (5-10 mg/day) significantly (P < 0.05) decreased baseline values of MSNA, which were accompanied by a significant (P < 0.05) increase in the reflex inhibition of MSNA, while plasma concentrations of noradrenaline were unaffected. 6. These results indicate that AngII blunts reflex inhibition of sympathetic neural activity and that inhibition of the renin-angiotensin system by an ACE inhibitor augments reflex regulation of sympathetic neural activity and reduces baseline values in patients with essential hypertension.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10549404     DOI: 10.1046/j.1440-1681.1999.03122.x

Source DB:  PubMed          Journal:  Clin Exp Pharmacol Physiol        ISSN: 0305-1870            Impact factor:   2.557


  7 in total

Review 1.  The global epidemic of obesity: are we becoming more sympathetic?

Authors:  Kevin P Davy
Journal:  Curr Hypertens Rep       Date:  2004-06       Impact factor: 5.369

2.  Eprosartan modulates the reflex activation of the sympathetic nervous system in sodium restricted healthy humans.

Authors:  Henrik Vase; Thomas G Lauridsen; Jesper N Bech; Erling B Pedersen
Journal:  Br J Clin Pharmacol       Date:  2008-03-13       Impact factor: 4.335

Review 3.  Blood pressure lowering efficacy of angiotensin converting enzyme (ACE) inhibitors for primary hypertension.

Authors:  Balraj S Heran; Michelle My Wong; Inderjit K Heran; James M Wright
Journal:  Cochrane Database Syst Rev       Date:  2008-10-08

Review 4.  Sympathetic Nervous System, Hypertension, Obesity and Metabolic Syndrome.

Authors:  Gino Seravalle; Guido Grassi
Journal:  High Blood Press Cardiovasc Prev       Date:  2016-03-04

Review 5.  Sympathetic nervous system behavior in human obesity.

Authors:  Kevin P Davy; Jeb S Orr
Journal:  Neurosci Biobehav Rev       Date:  2008-05-28       Impact factor: 8.989

6.  Chronic inhibition of endothelial nitric oxide synthase activity in nucleus tractus solitarii enhances baroreceptor reflex in conscious rats.

Authors:  Hidefumi Waki; Sergey Kasparov; Liang-Fong Wong; David Murphy; Tsuyoshi Shimizu; Julian F R Paton
Journal:  J Physiol       Date:  2003-01-01       Impact factor: 5.182

7.  ACE inhibition for severe bronchopulmonary dysplasia - an approach based on physiology.

Authors:  Arvind Sehgal; Mohan B Krishnamurthy; Megan Clark; Samuel Menahem
Journal:  Physiol Rep       Date:  2018-09
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.